Study of the Effects of AngiotensinⅡon the Male Rats with Diabetic Erectile Dysfunction

Dai Yutian,Li Sanxiang,Chen Yun,Yao Leshen,Wen Duangai

DOI: https://doi.org/10.3969/j.issn.1008-0848.2006.08.003

2006-01-01

Abstract:Objective To investigate the changes of angiotensinⅡ(AngⅡ) and its receptors (AT1) on the male rates with diabetic erectile dysfunction(DED) so as to study its effects. Methods The research can be divided into two parts. First part: After the models of diabetic rats were induced,they had been fed for 8 weeks. Then the rats with erectile dysfunction were selected from these models. All rats were divided into 3 groups: control, diabetes mellitus(DM) and DED. For each rat, the AngⅡlevels of blood and homogenate prepared from a part of isolated penile tissues were determined respectively, and the AngⅡreceptors of the rest of penile tissues were analyzed through immunohistochemical (IHC) assay. Second part: All rats were divided into three groups after the models of diabetic rats were set up: DM(no treatment), Valsartan and Spironolactone group. After 8 weeks of treatment, we used emetomorphine (APO) and intracavernous pressure (ICP) to value the improvement of erection of experimental rats. Results Compared with the control group, AngⅡlevels of blood and penile tissue in DM group ,as well as the level of blood in DED group, were very high and differences were significant statistically (P<0.05). AngⅡof tissue in DED increased sharply (P<0.001). The receptors of AngⅡchanged oppositely against level of AngⅡ. Compared with the control group, the erection frequency and value of ICP in rats of Valsartan treated group were both increased significantly. Conclusion AngⅡmay play an important role in the pathogenesis of DED, and AT1 antagonist of the angiotensin-converting enzyme (ACE) may become a therapeutic method for DED in future.